Development of a Diagnostic Nomogram to Predict CAP in Hospitalized Patients with AECOPD

References

• Labaki WW, Rosenberg SR. Chronic obstructive pulmonary disease screening. Ann Intern Med. 2020;173(3):ITC17–ITC32. doi: 10.7326/AITC202008040.
   PubMed Web of Science ®Google Scholar
• Soriano JB, Kendrick PJ, Paulson KR, et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Respirat Med. 2020;8(6):585–596. doi: 10.1016/S2213-2600(20)30105-3.
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TAR, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–852. doi: 10.1136/thorax.57.10.847.
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1418–1422. doi: 10.1164/ajrccm.157.5.9709032.
   PubMed Web of Science ®Google Scholar
• Hilleman DE, Dewan N, Malesker M, et al. Pharmacoeconomic evaluation of COPD. Chest. 2000;118(5):1278–1285. doi: 10.1378/chest.118.5.1278.
   PubMed Web of Science ®Google Scholar
• Soler-Cataluna JJ. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. doi: 10.1136/thx.2005.040527.
   PubMed Web of Science ®Google Scholar
• Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;184(6):662–671. doi: 10.1164/rccm.201104-0597OC.
   PubMed Web of Science ®Google Scholar
• Steer J, Norman EM, Afolabi OA, et al. Dyspnoea severity and pneumonia as predictors of in-hospital mortality and early readmission in acute exacerbations of COPD. Thorax. 2012;67(2):117–121. doi: 10.1136/thoraxjnl-2011-200332.
   PubMed Web of Science ®Google Scholar
• Søgaard M, Madsen M, Løkke A, et al. Incidence and outcomes of patients hospitalized with COPD exacerbation with and without pneumonia. COPD. 2016;11:455–465. doi: 10.2147/COPD.S96179.
   Google Scholar
• Mandell LA, Wunderink RG, Anzueto A, et al. Infectious diseases society of america/American thoracic society consensus guidelines on the management of Community-Acquired pneumonia in adults. Clin Infect Dis. 2007;44(Supplement_2):S27–S72. doi: 10.1086/511159.
   PubMed Web of Science ®Google Scholar
• Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64(Suppl 3):iii1–iii55. doi: 10.1136/thx.2009.121434.
   PubMed Web of Science ®Google Scholar
• Claessens Y, Debray M, Tubach F, et al. Early chest computed tomography scan to assist diagnosis and guide treatment decision for suspected community-acquired pneumonia. Am J Respir Crit Care Med. 2015;192(8):974–982. doi: 10.1164/rccm.201501-0017OC.
   PubMed Web of Science ®Google Scholar
• Claessens Y, Berthier F, Baqué-Juston M, et al. Early chest CT-scan in emergency patients affected by community-acquired pneumonia is associated with improved diagnosis consistency. Eur J Emerg Med. 2022;29(6):417–420. doi: 10.1097/MEJ.0000000000000955.
   PubMed Web of Science ®Google Scholar
• Mou S, Zhang W, Deng Y, et al. Comparison of CRP, procalcitonin, neutrophil counts, eosinophil counts, sTREM-1, and OPN between pneumonic and nonpneumonic exacerbations in COPD patients. Can Respir J. 2022;2022:1–9. doi: 10.1155/2022/7609083.
   Web of Science ®Google Scholar
• C M, S TP, P J, et al. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–1251.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2020. www.goldcopd.org.
   Google Scholar
• Cao B, Huang Y, She DY, et al. Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the chinese thoracic society, chinese medical association. Clin Respir J. 2018;12(4):1320–1360. doi: 10.1111/crj.12674.
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196–204. doi: 10.7326/0003-4819-106-2-196.
   PubMed Web of Science ®Google Scholar
• Dessai SB, Fasal R, Dipin J, et al. Age-adjusted charlson comorbidity index and 30-day morbidity in pelvic surgeries. South Asian J. Cancer. 2020;7(4):240–243.
   Web of Science ®Google Scholar
• Hausfater P. Biomarkers and infection in the emergency unit. Med Mal Infect. 2014;44(4):139–145. doi: 10.1016/j.medmal.2014.01.002.
   PubMed Web of Science ®Google Scholar
• Halıcı A, Hür 0, Abatay K, et al. The role of presepsin in the diagnosis of chronic obstructive pulmonary disease acute exacerbation with pneumonia. Biomark Med. 2020;14(1):31–41. doi: 10.2217/bmm-2019-0183.
   PubMed Web of Science ®Google Scholar
• Wiedermann CJ. Hypoalbuminemia as surrogate and culprit of infections. IJMS. 2021;22(9):4496. doi: 10.3390/ijms22094496.
   Google Scholar
• Mayhew D, Devos N, Lambert C, et al. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations. Thorax. 2018;73(5):422–430. doi: 10.1136/thoraxjnl-2017-210408.
   PubMed Web of Science ®Google Scholar
• Mallia P, Footitt J, Sotero R, et al. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(11):1117–1124. doi: 10.1164/rccm.201205-0806OC.
   PubMed Web of Science ®Google Scholar
• Wark PAB, Tooze M, Powell H, et al. Viral and bacterial infection in acute asthma and chronic obstructive pulmonary disease increases the risk of readmission. Respirology. 2013;18(6):996–1002. doi: 10.1111/resp.12099.
   PubMed Web of Science ®Google Scholar
• Martínez-García MÁ, de la Rosa-Carrillo D, Soler-Cataluña JJ, et al. Bronchial infection and temporal evolution of bronchiectasis in patients with chronic obstructive pulmonary disease. Clin Infect Dis. 2021;72(3):403–410. doi: 10.1093/cid/ciaa069.
   PubMed Web of Science ®Google Scholar
• Vespasiani-Gentilucci U, De Vincentis A, Ferrucci L, et al. Low alanine aminotransferase levels in the elderly population: frailty, disability, sarcopenia, and reduced survival. J Gerontol A Biol Sci Med Sci. 2018;73(7):925–930. doi: 10.1093/gerona/glx126.
   PubMed Web of Science ®Google Scholar
• Cillóniz C, Rodríguez-Hurtado D, Torres A. Characteristics and management of Community-Acquired pneumonia in the era of global aging. Med Sci. 2018;6(2):35. doi: 10.3390/medsci6020035.
   Google Scholar
• Almagro P, Cabrera FJ, Diez J, et al. Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en servicios de medicina interna (ESMI) study. Chest. 2012;142(5):1126–1133. doi: 10.1378/chest.11-2413.
   PubMed Web of Science ®Google Scholar
• Seo H, Sim YS, Min KH, et al. The relationship between comorbidities and microbiologic findings in patients with acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2022;17:855–867. doi: 10.2147/COPD.S360222.
   PubMed Web of Science ®Google Scholar
• Wedzicha JA, Calverley PMA, Seemungal TA, et al. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med. 2008;177(1):19–26. doi: 10.1164/rccm.200707-973OC.
   PubMed Web of Science ®Google Scholar
• Halpin DMG, Gray J, Edwards SJ, et al. Budesonide/formoterol vs. salmeterol/fluticasone in COPD: a systematic review and adjusted indirect comparison of pneumonia in randomised controlled trials. Int J Clin Pract. 2011;65(7):764–774. doi: 10.1111/j.1742-1241.2011.02685.x.
   PubMed Web of Science ®Google Scholar
• Kendzerska T, Aaron SD, To T, et al. Effectiveness and safety of inhaled corticosteroids in older individuals with chronic obstructive pulmonary disease and/or asthma. A population study. Ann Am Thorac Soc. 2019;16(10):1252–1262. doi: 10.1513/AnnalsATS.201902-126OC.
   PubMed Web of Science ®Google Scholar
• Lee S, Lee H, Park H. Transcriptome analysis of sputum cells reveals two distinct molecular phenotypes of "asthma and chronic obstructive pulmonary disease overlap" in the elderly. Eur J Med Res. 2022;27(1):215. doi: 10.1186/s40001-022-00861-2.
   PubMed Web of Science ®Google Scholar
• Leigh R, Pizzichini MMM, Morris MM, et al. Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. Eur Respir J. 2006;27(5):964–971. doi: 10.1183/09031936.06.00072105.
   PubMed Web of Science ®Google Scholar
• Titova E, Christensen A, Henriksen AH, et al. Comparison of procalcitonin, C-reactive protein, white blood cell count and clinical status in diagnosing pneumonia in patients hospitalized with acute exacerbations of COPD: a prospective observational study. Chron Respir Dis. 2019;16:147997231876976. doi: 10.1177/1479972318769762.
   Web of Science ®Google Scholar